Why we are bullish on emerging market equities in 2021 Why we are bullish on emerging market equities in 2021 Why we are bullish on emerging market equities in 2021

Why we are bullish on emerging market equities in 2021

Equities 6 minutes to read
PG
Peter Garnry

Head of Equity Strategy

Summary:  Our guess is that emerging market equities next year will do great as Asia is coming out of the Covid-19 pandemic much stronger than the developed world. China will most likely ease its financial conditions through monetary policy in the early part of 2021 lifting sentiment but also valuation multiples on emerging market equities. In 2021, earnings in emerging markets will come roaring back at an even more impressive rate than in the developed world creating a power positive tailwind of earnings surprises and strong earnings growth.


This week is starting with a clear divergence across equity markets with momentum stocks down (that is technology stocks) and the broader market bid indicating the value trade is being put on again. As we wrote on Friday, we would like to see the US 10-year yield move above 1-1.1% before we call the big rotation into value stocks.  We are also observing emerging market equities being the best performing segment this morning on the backdrop of much better than expected South Korea exports y/y (first 20 days of November) out at 11.1% vs. est. -5.8% suggesting the cyclical part of the economy is really heating up. With China’s industrial growth back to levels seen before the Covid-19 pandemic there are many indicators suggesting strong growth in Asia which will reflect positively on emerging market equities which are driven by equities in South Korea, China, Taiwan and India.

Source: Bloomberg

Emerging market equities have outperformed developed equities by 10.5% since late June as sentiment has changed to the stance that the main emerging market indices (China, Taiwan, South Korea and India) will come out stronger as this part of the world has managed the pandemic much better than many developed market countries. The relative performance between emerging markets and developed markets also suggest that this a mean-reversion trade as emerging markets have underperformed for years as investors have focused on US technology and health care stocks.

Source: Bloomberg

One of the main reasons behind our positive view is that we guess China will ease its financial conditions through easier monetary policy. In many ways, China is running too tight financial conditions which have consistently strengthened the currency against the USD, but the length of these tighter conditions are now becoming an issue for export growth and the parts of the economy related to real estate. We expect China to ease monetary policy in 2021 which could lift equities through expanding valuation multiples.

Source: Bloomberg

Our other argument for being long emerging markets is that Chinese stimulus and a better positioned Asian economy will lift earnings considerably from current low levels. Analysts expect earnings to increase by 43% over the next 12 months which will likely create a lot of positive tailwind from earnings exceeding expectations and growing fast on a y/y basis which tend to lift sentiment. Analysts also discount 11-15% earnings growth in the years after 2021 which should also materialize in higher equity prices as investors will continue to look for growth.

Source: Bloomberg
Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.